Focus on immunotherapy and patient perspective at IASLC 2019 Small Cell Lung Cancer Meeting
Denver — (March 27, 2019) — While non-small cell lung cancer (NSCLC) is the more common form of lung cancer and attracts the lion’s share of the research funding, recent developments in small cell lung cancer may be shifting that slightly. In order to capitalize on these recent developments, researchers who focus on small cell…